VYNE Historical PE Ratio image   This VYNE PE ratio history page last updated 8/18/2023
VYNE PE History Chart
PeriodPriceAdj. EPSTTMPE
Q2 2023
8/14/2023
6.01-2.82-9.79NA
Q1 2023
5/11/2023
6.10-1.48-9.31NA
Q4 2022
3/9/2023
3.00-2.97-6.03NA
Q3 2022
11/10/2022
4.50-2.52-6.66NA
Q2 2022
8/12/2022
5.69-2.34-10.62NA
Q1 2022
5/12/2022
6.681.80-14.58NA
Q4 2021
3/17/2022
10.98-3.60-23.04NA
Q3 2021
11/10/2021
23.58-6.48-27.18NA
Q2 2021
8/12/2021
35.82-6.30-30.06NA
Q1 2021
5/6/2021
64.08-6.66-27.04NA
Q4 2020
3/4/2021
120.24-7.74-24.18NA
Q3 2020
11/5/2020
127.44-9.36-20.00NA
Q2 2020
8/6/2020
114.48-3.28-13.44NA
Q1 2020
5/11/2020
132.48-3.80-12.92NA
Q4 2019
3/3/2020
198.00-3.56-12.36NA
Q3 2019
10/31/2019
365.04-2.80-11.84NA
Q2 2019
8/1/2019
249.84-2.76-11.28NA
Q1 2019
5/2/2019
504.00-3.24NANA
Q4 2018
2/27/2019
609.12-3.04NANA
Q3 2018
11/7/2018
511.92-2.24NANA
VYNE Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q2 2023
8/14/2023
6.01-2.82-11.28NA
Q1 2023
5/11/2023
6.10-1.48-5.92NA
Q4 2022
3/9/2023
3.00-2.97-11.88NA
Q3 2022
11/10/2022
4.50-2.52-10.08NA
Q2 2022
8/12/2022
5.69-2.34-9.36NA
Q1 2022
5/12/2022
6.681.807.200.9
Q4 2021
3/17/2022
10.98-3.60-14.40NA
Q3 2021
11/10/2021
23.58-6.48-25.92NA
Q2 2021
8/12/2021
35.82-6.30-25.20NA
Q1 2021
5/6/2021
64.08-6.66-26.64NA
Q4 2020
3/4/2021
120.24-7.74-30.96NA
Q3 2020
11/5/2020
127.44-9.36-37.44NA
Q2 2020
8/6/2020
114.48-3.28-13.12NA
Q1 2020
5/11/2020
132.48-3.80-15.20NA
Q4 2019
3/3/2020
198.00-3.56-14.24NA
Q3 2019
10/31/2019
365.04-2.80-11.20NA
Q2 2019
8/1/2019
249.84-2.76-11.04NA
Q1 2019
5/2/2019
504.00-3.24-12.96NA
Q4 2018
2/27/2019
609.12-3.04-12.16NA
Q3 2018
11/7/2018
511.92-2.24-8.96NA
Quotes delayed 20 minutes

Email EnvelopeFree VYNE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
VYNE Therapeutics (VYNE) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

VYNT PE Ratio History
WAT PE Ratio History
WGS PE Ratio History
WINT PE Ratio History
WST PE Ratio History
XAIR PE Ratio History
XBIO PE Ratio History
XCUR PE Ratio History
XENT PE Ratio History
XERS PE Ratio History
On this page we presented the VYNE PE Ratio History information for VYNE Therapeutics' stock. The average VYNE PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 0.9. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average VYNE PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this VYNE PE ratio history result, against the recent PE: when this page was posted on 8/17/2023, the most recent closing price for VYNE had been 4.72, and the most recent quarterly earnings result, annualized, was 7.2. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent VYNE PE on 8/17/2023 based on annualized quarterly EPS was 0.7. Based on VYNE's history, that recent PE is low relative to the historical average, with the recent PE 22.2% lower than the historical average PE across our data set for VYNE Therapeutics.

For self directed investors doing their due diligence on VYNE or any other given stock, valuation analysis for VYNE can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate VYNE Therapeutics PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for VYNE. Thanks for visiting, and the next time you need to research VYNE PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: EPM Dividend Growth Rate, Funds Holding REIS, Funds Holding TMC.

 

VYNE PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2023, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 7.8%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 7.8%.